Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
- Conditions
- Interventions
- First Posted Date
- 2010-03-01
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 126
- Registration Number
- NCT01077960
- Locations
- 🇨🇦
St Paul Hospital, Vancouver, British Columbia, Canada
🇺🇸University of Alabama/Birmingham, Birmingham, Alabama, United States
🇺🇸Care Clinic, Los Angeles, California, United States
EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Conditions
- Interventions
- First Posted Date
- 2009-12-30
- Last Posted Date
- 2017-01-30
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 107
- Registration Number
- NCT01040832
- Locations
- 🇭🇺
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Hungary
🇭🇺Zala Megyei Kohaz Kulsokorhaz Onkologia Osztaly, Zalaegerszeg, Hungary
🇵🇱SPZOZ Centrum Onkologi Liemi Lubelskiej, II Odzial Radioterapiii z pododdzialem Chemioterpii, Lublin, Poland
A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study
- Conditions
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2013-08-08
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 103
- Registration Number
- NCT01036165
- Locations
- 🇺🇸
EMD Serono, Inc., Rockland, Massachusetts, United States
r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence Trial
- Conditions
- Interventions
- First Posted Date
- 2009-12-17
- Last Posted Date
- 2013-10-23
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 30
- Registration Number
- NCT01034735
- Locations
- 🇩🇪
AAI Pharma Deutschland GmbH & Co. KG, Neu-Ulm, Germany
The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial
- First Posted Date
- 2009-12-17
- Last Posted Date
- 2014-03-10
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 324
- Registration Number
- NCT01034579
- Locations
- 🇺🇸
Please Contact U.S. Medical Information Located in, Rockland, Massachusetts, United States
Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-11-19
- Last Posted Date
- 2017-07-13
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 141
- Registration Number
- NCT01016483
- Locations
- 🇺🇸
For Recruiting Locations in the United States, please Contact U.S. Medical Information, Rockland, Massachusetts, United States
🇩🇪For Recruiting Locations outside the United States, Please contact the Merck KGaA Communication Center, Darmstadt, Germany
First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2009-11-17
- Last Posted Date
- 2022-08-24
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 149
- Registration Number
- NCT01014936
- Locations
- 🇺🇸
M.D. Anderson Cancer Center, Houston, Texas, United States
Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials
- Conditions
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2019-11-15
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 1161
- Registration Number
- NCT01013350
- Locations
- 🇺🇸
Outcome Sciences, Inc, Cambridge, Massachusetts, United States
The Multicenter, Open-label, Single-use Autoinjector Convenience Study
- Conditions
- First Posted Date
- 2009-08-13
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 109
- Registration Number
- NCT00958009
- Locations
- 🇺🇸
EMD Serono, Inc., Rockland, Massachusetts, United States
Trial of Pimasertib in Hematological Malignancies
- Conditions
- Interventions
- First Posted Date
- 2009-08-12
- Last Posted Date
- 2017-08-21
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 81
- Registration Number
- NCT00957580
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States